Return to study ST000096 main page

Download data matrix(A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: UPLC-QTRAP MS analysis Oxylipins analysis,Negative)

Download data matrix(A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: UPLC-QTRAP MS analysis Ceramide analysis, Positive)

Download data matrix(A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: UPLC-QTRAP MS analysis Endocannabinoid analysis, positive)

AnalysisSamplesFactorsUnits
Oxylipins analysis,NegativeS29ASample Type:Adipocyte | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS30ASample Type:Adipocyte | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS31ASample Type:Adipocyte | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS32ASample Type:Adipocyte | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS33ASample Type:Adipocyte | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS34ASample Type:Adipocyte | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS35ASample Type:Adipocyte | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS17ASample Type:Adipocyte | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeS19ASample Type:Adipocyte | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeS20ASample Type:Adipocyte | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeS23ASample Type:Adipocyte | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeS24ASample Type:Adipocyte | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeS25ASample Type:Adipocyte | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeS26ASample Type:Adipocyte | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeS29CSample Type:Co-culture | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS30CSample Type:Co-culture | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS31CSample Type:Co-culture | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS32CSample Type:Co-culture | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS33CSample Type:Co-culture | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS34CSample Type:Co-culture | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS35CSample Type:Co-culture | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS17CSample Type:Co-culture | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeS19CSample Type:Co-culture | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeS20CSample Type:Co-culture | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeS23CSample Type:Co-culture | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeS24CSample Type:Co-culture | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeS25CSample Type:Co-culture | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeS26CSample Type:Co-culture | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeS29BSample Type:Control | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS30BSample Type:Control | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS31BSample Type:Control | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS32BSample Type:Control | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS33BSample Type:Control | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS34BSample Type:Control | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS35BSample Type:Control | Timepoint:18 hoursArea %
Oxylipins analysis,NegativeS17BSample Type:Control | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeS19BSample Type:Control | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeS20BSample Type:Control | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeS23BSample Type:Control | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeS24BSample Type:Control | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeS25BSample Type:Control | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeS26BSample Type:Control | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeMedia blankSample Type:Media blank | Timepoint:4 hoursArea %
Oxylipins analysis,NegativeBlank mediaSample Type:Media blank | Timepoint:NAArea %
Ceramide analysis, PositiveS29ASample Type:Adipocyte | Timepoint:18 hoursnM
Ceramide analysis, PositiveS30ASample Type:Adipocyte | Timepoint:18 hoursnM
Ceramide analysis, PositiveS31ASample Type:Adipocyte | Timepoint:18 hoursnM
Ceramide analysis, PositiveS32ASample Type:Adipocyte | Timepoint:18 hoursnM
Ceramide analysis, PositiveS33ASample Type:Adipocyte | Timepoint:18 hoursnM
Ceramide analysis, PositiveS34ASample Type:Adipocyte | Timepoint:18 hoursnM
Ceramide analysis, PositiveS35ASample Type:Adipocyte | Timepoint:18 hoursnM
Ceramide analysis, PositiveS17ASample Type:Adipocyte | Timepoint:4 hoursnM
Ceramide analysis, PositiveS19ASample Type:Adipocyte | Timepoint:4 hoursnM
Ceramide analysis, PositiveS20ASample Type:Adipocyte | Timepoint:4 hoursnM
Ceramide analysis, PositiveS23ASample Type:Adipocyte | Timepoint:4 hoursnM
Ceramide analysis, PositiveS24ASample Type:Adipocyte | Timepoint:4 hoursnM
Ceramide analysis, PositiveS25ASample Type:Adipocyte | Timepoint:4 hoursnM
Ceramide analysis, PositiveS26ASample Type:Adipocyte | Timepoint:4 hoursnM
Ceramide analysis, PositiveS29CSample Type:Co-culture | Timepoint:18 hoursnM
Ceramide analysis, PositiveS30CSample Type:Co-culture | Timepoint:18 hoursnM
Ceramide analysis, PositiveS31CSample Type:Co-culture | Timepoint:18 hoursnM
Ceramide analysis, PositiveS32CSample Type:Co-culture | Timepoint:18 hoursnM
Ceramide analysis, PositiveS33CSample Type:Co-culture | Timepoint:18 hoursnM
Ceramide analysis, PositiveS34CSample Type:Co-culture | Timepoint:18 hoursnM
Ceramide analysis, PositiveS35CSample Type:Co-culture | Timepoint:18 hoursnM
Ceramide analysis, PositiveS17CSample Type:Co-culture | Timepoint:4 hoursnM
Ceramide analysis, PositiveS19CSample Type:Co-culture | Timepoint:4 hoursnM
Ceramide analysis, PositiveS20CSample Type:Co-culture | Timepoint:4 hoursnM
Ceramide analysis, PositiveS23CSample Type:Co-culture | Timepoint:4 hoursnM
Ceramide analysis, PositiveS24CSample Type:Co-culture | Timepoint:4 hoursnM
Ceramide analysis, PositiveS25CSample Type:Co-culture | Timepoint:4 hoursnM
Ceramide analysis, PositiveS26CSample Type:Co-culture | Timepoint:4 hoursnM
Ceramide analysis, PositiveS29BSample Type:Control | Timepoint:18 hoursnM
Ceramide analysis, PositiveS30BSample Type:Control | Timepoint:18 hoursnM
Ceramide analysis, PositiveS31BSample Type:Control | Timepoint:18 hoursnM
Ceramide analysis, PositiveS32BSample Type:Control | Timepoint:18 hoursnM
Ceramide analysis, PositiveS33BSample Type:Control | Timepoint:18 hoursnM
Ceramide analysis, PositiveS34BSample Type:Control | Timepoint:18 hoursnM
Ceramide analysis, PositiveS35BSample Type:Control | Timepoint:18 hoursnM
Ceramide analysis, PositiveS17BSample Type:Control | Timepoint:4 hoursnM
Ceramide analysis, PositiveS19BSample Type:Control | Timepoint:4 hoursnM
Ceramide analysis, PositiveS20BSample Type:Control | Timepoint:4 hoursnM
Ceramide analysis, PositiveS23BSample Type:Control | Timepoint:4 hoursnM
Ceramide analysis, PositiveS24BSample Type:Control | Timepoint:4 hoursnM
Ceramide analysis, PositiveS25BSample Type:Control | Timepoint:4 hoursnM
Ceramide analysis, PositiveS26BSample Type:Control | Timepoint:4 hoursnM
Ceramide analysis, PositiveMedia blankSample Type:Media blank | Timepoint:4 hoursnM
Ceramide analysis, PositiveBlank mediaSample Type:Media blank | Timepoint:NAnM
Endocannabinoid analysis, positiveS29ASample Type:Adipocyte | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveS30ASample Type:Adipocyte | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveS31ASample Type:Adipocyte | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveS32ASample Type:Adipocyte | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveS33ASample Type:Adipocyte | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveS34ASample Type:Adipocyte | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveS35ASample Type:Adipocyte | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveS29CSample Type:Co-culture | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveS30CSample Type:Co-culture | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveS31CSample Type:Co-culture | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveS32CSample Type:Co-culture | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveS33CSample Type:Co-culture | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveS34CSample Type:Co-culture | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveS35CSample Type:Co-culture | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveS29BSample Type:Control | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveS30BSample Type:Control | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveS31BSample Type:Control | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveS32BSample Type:Control | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveS33BSample Type:Control | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveS34BSample Type:Control | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveS35BSample Type:Control | Timepoint:18 hoursnM
Endocannabinoid analysis, positiveBlank mediaSample Type:Media blank | Timepoint:NAnM
  logo